Abstract |
Intraductal papillary- mucinous carcinoma (IPMC) of the pancreas, a new entity of pancreatic cancer with a favorable prognosis, has shown a gradual increase in the number of reported cases. Patients with high-frequency microsatellite instability (MSI-H) tumors have been shown to survive longer than those with low-frequency MSI (MSI-L) or microsatellite stable (MSS) tumors in colorectal and gastric cancer. We investigated whether MSI-H in patients with IPMC can contribute to a good prognosis. The formalin-fixed paraffin-embedded tumors and surrounding normal pancreatic tissues from 10 patients with IPMCs and 16 with intraductal papillary-mucinous adenomas (IPMAs) were provided for DNA extraction after microdissection. Polymerase chain reaction (PCR) was carried out using 8 microsatellite primer marker sets. The mixed PCR samples were analyzed using a genetic analyzer. MSI-H was determined by assessment of microsatellite variations in 3 or more of the 8 tested markers. Immunohistochemical staining of the MSI-responsible proteins hMLH1 and hMSH2 was conducted for both the IPMC and IPMA samples. Ten percent of IPMC harbored MSI-H tumors, whereas no MSI-H tumors were detected in the IPMAs. Thirty percent of IPMC tumors and 25% of IPMA tumors showed MSI-L. All IPMCs and IPMAs showed normal expression of both hMLH1 and hMSH2. MSI-H and loss of hMLH1 and hMSH2 are very rare events in both IPMCs and IPMAs. We conclude that a good prognosis for patients with IPMC is not associated with MSI-H.
|
Authors | Bunzo Nakata, Masakazu Yashiro, Nobuaki Nishioka, Makoto Aya, Shinobu Yamada, Chiemi Takenaka, Masaichi Ohira, Tetsuro Ishikawa, Hiroji Nishino, Kenichi Wakasa, Shuichi Seki, Kosei Hirakawa |
Journal | International journal of cancer
(Int J Cancer)
Vol. 102
Issue 6
Pg. 655-9
(Dec 20 2002)
ISSN: 0020-7136 [Print] United States |
PMID | 12448010
(Publication Type: Journal Article)
|
Copyright | Copyright 2002 Wiley-Liss, Inc. |
Chemical References |
- Adaptor Proteins, Signal Transducing
- Carrier Proteins
- DNA-Binding Proteins
- MLH1 protein, human
- Neoplasm Proteins
- Nuclear Proteins
- Proto-Oncogene Proteins
- SMAD4 protein, human
- Smad4 Protein
- Trans-Activators
- MSH2 protein, human
- MutL Protein Homolog 1
- MutS Homolog 2 Protein
|
Topics |
- Adaptor Proteins, Signal Transducing
- Adenocarcinoma, Mucinous
(genetics)
- Aged
- Carcinoma, Pancreatic Ductal
(genetics)
- Carcinoma, Papillary
(genetics)
- Carrier Proteins
- DNA-Binding Proteins
(genetics)
- Female
- Genes, p16
- Genes, p53
- Humans
- Immunohistochemistry
- Incidence
- Male
- Microsatellite Repeats
- Middle Aged
- MutL Protein Homolog 1
- MutS Homolog 2 Protein
- Neoplasm Proteins
(analysis, genetics)
- Nuclear Proteins
- Pancreatic Neoplasms
(genetics)
- Proto-Oncogene Proteins
(analysis, genetics)
- Smad4 Protein
- Trans-Activators
(genetics)
|